ArticleJAMA network open2025
Use of Tobacco and Cannabis Following State-Level Cannabis Legalization.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Emergency department use by individuals with and without psychosis after state-level cannabis legalization and commercialization.Nature. Mental health · 2026Article
- Cannabis legalization and early adolescent expectancies: Findings from the adolescent brain cognitive development study.Drug and alcohol dependence · 2026Article
- How Consumers Transition Between Illicit and Legal Cannabis Markets in Early Legalization Periods? Evidence from a National Panel with a Recent Policy Shock.Research square · 2026Article
- Effects of textual warnings and warning symbols on cannabis advertisements on product perceptions among US young adults.Health education research · 2026Article
- Recent Trends in Cannabis Use in Adults Ages 60 Years and Older.Substance abuse and rehabilitation · 2026Review
- Cannabis Use Among Individuals With Psychosis After State-Level Commercial Cannabis Legalization.JAMA psychiatry · 2026Article
- Cannabis, psychosis, and violence: case reports and comprehensive evidence review.Frontiers in psychiatry · 2026Article
- Adult-use cannabis legalization in the united states: a scoping review of outcome monitoring recommendations.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Importance: Cannabis use has been shown to modestly increase shortly after legalization of recreational use, but little is known about longer-term changes in cannabis and tobacco use. Objective: To assess the association of cannabis legalization and commercialization with the use of cannabis, cigarettes, and electronic nicotine delivery systems (ENDS) in the 5 years after legalization in the US. Design, Setting, and Participants: The Population Assessment of Tobacco and Health (PATH) study, a nationally representative longitudinal cohort study of adults 18 years or older in the US, was used for a retrospective, difference-in-differences analysis of panel data from January 2013 to December 2022. Data were analyzed from May 8, 2024, to April 20, 2025. Exposures: State-level recreational cannabis legalization (RCL) and opening of retail outlets with 5 years of follow-up. Main Outcomes and Measures: Percentage point changes in 30-day use of cannabis, cigarettes, and ENDS in states with legalization compared with control states, aggregated over 5 years and then broken down into the periods before and after retail outlets opened. Results: Among the 171 257 observations from 55 406 individuals included in the analysis (50.9% female; mean [SD] age, 37.97 [17.69] years), RCL was associated with an increase of cannabis use by 3.28 (95% CI, 2.29-4.27) percentage points and ENDS use by 1.39 (95% CI, 0.44-2.35) percentage points compared with control states. There was no differential change in cigarette use (-0.99 [95% CI, -2.25 to 0.27] percentage points). For cannabis, this change was greater after retail outlets opened (3.74 [95% CI, 2.65-4.82] percentage points) compared with before (1.17 [95% CI, 0.13-2.20] percentage points). There were no large changes in ENDS or cigarette use associated with the opening of retail outlets. Conclusions and Relevance: In this longitudinal cohort study, RCL was associated with more cannabis and ENDS use after 5 years and no significant change in cigarette use. Furthermore, cannabis use increased over time, underscoring the importance of studying commercialization policy going forward. Based on the present results, it is unlikely RCL has been associated with a large increase in cigarette use, but increases in use of cannabis and vaped nicotine bear close monitoring as retail cannabis rapidly expands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.